Open AccessSurrogacy and HIV: features of a clinical case in comorbid cancer
Author(s) -
T. V. Lisovskaya,
С. С. Смирнова,
A. M. Gzgyan,
Dmitry Kireev,
Д. Ф. Салимов,
Р. Е. Попов,
Ю. Е. Буев
Publication year - 2021
Publication title -
uralʹskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2949-4389
pISSN - 2071-5943
DOI - 10.52420/2071-5943-2021-20-1-65-69
Subject(s) - infertility , medicine , life expectancy , fertility , disease , oncofertility , human immunodeficiency virus (hiv) , cancer , stage (stratigraphy) , family medicine , quality of life (healthcare) , legislation , intensive care medicine , pregnancy , gynecology , fertility preservation , nursing , environmental health , biology , paleontology , population , genetics , political science , law
. A significant increase in the quality and increase in the life expectancy of HIV patients during treatment with antiretroviral drugs necessitates the implementation of the reproductive function in these patients. The participation of a surrogate mother in the treatment of infertility in HIV-infected potential parents, vided by the Russian legislation, requires additional solutions to a number of clinical and organizational problems. The aim was to substantiate a surrogacy program as a method of choice for the treatment of infertility in patients with HIV-positive status and comorbid cancer and also a multidisciplinary approach to organizing it on the example of a specific clinical situation and based on the analysis literature data. Materials. We report a case of using a surrogacy program for a married couple with a positive HIV status in the 4th stage of the disease using the husband's sperm and donor oocytes. The use of donor oocytes in this situation is due to the onset of menopause against the background of a comorbid severe cancer that required multiple courses of chemotherapy. Conclusion. Potential biological parents with a positive HIV status in stage 4 of the disease may have a comorbid oncological pathology, which in itself, as well as its treatment, contributes to a decrease in fertility, and for the future biological mother, it is an obstacle to independently carrying a pregnancy. In this regard, the surrogacy program is the method of choice for the treatment of infertility in this clinical situation. It is advisable for obstetricians-gynecologists (reproductologists) to inform the surrogate mother about the potential risks of infection with the participation of genetic parents with HIV-positive status at various stages of IVF and about preventive measures during gestation in conjunction with the infectious disease specialist of the regional centers for the prevention and control of AIDS.